MP22 Policy for prescribing anti-psychotic medications in psychotic conditions (excluding Bipolar Disorder)
Target Audience
All clinical staff
Purpose
The Antipsychotic Task & Finish Group, Prescribers within the Trust have been consulted with at various events, such as the Masterclass in Psychopharmacology study day and local Consultant & Managers (CONMAN) meetings, to give their opinion regarding antipsychotic prescribing
Origin
Lead executive
Medical Director
Author and contact number
Lead Clinical Pharmacist
01625 663857
Policy dates & history
Implementation Date
30 November 2011
Review Date
30 November 2016
Approval Meeting
Medicines Management Group (MMG)
Ratification
Document Quality Group (DQG)